Abstract
摘要
相似文献
1
Poliomyelitis vaccines.脊髓灰质炎疫苗
Lancet. 1977 Jul 2;2(8027):21-2.
2
[Immunization against poliomyelitis].[脊髓灰质炎免疫接种]
Bol Oficina Sanit Panam. 1972 Dec;73(6):516-27.
3
THE FUTURE OF INACTIVATED POLIOMYELITIS VACCINES.灭活脊髓灰质炎疫苗的未来
Proc R Soc Med. 1964 Jun;57(6):462-4. doi: 10.1177/003591576405700609.
4
Oral poliomyelitis vaccines.口服脊髓灰质炎疫苗
Lancet. 1996 May 25;347(9013):1496.
5
Oral poliomyelitis vaccines.口服脊髓灰质炎疫苗
Lancet. 1996 May 25;347(9013):1495-6.
6
Poliomyelitis prevention: enhanced-potency inactivated poliomyelitis vaccine--supplementary statement.
MMWR Morb Mortal Wkly Rep. 1987 Dec 11;36(48):795-8.
7
Leads from the MMWR. Poliomyelitis prevention: enhanced-potency inactivated poliomyelitis vaccine--supplementary statement.
JAMA. 1988 Jan 15;259(3):345-6.
8
Poliomyelitis vaccines. Success and controversy.脊髓灰质炎疫苗。成功与争议。
Infect Dis Clin North Am. 1990 Mar;4(1):75-83.
9
Decision analysis in planning for a polio outbreak in the United States.美国脊髓灰质炎疫情应对规划中的决策分析
Pediatrics. 2006 Aug;118(2):611-8. doi: 10.1542/peds.2005-2358.
10
Poliomyelitis: need forcontinued vigilance.脊髓灰质炎：仍需持续警惕。
Lancet. 1969 Nov 22;2(7630):1116.
引用本文的文献
1
Bromocriptine in Parkinson's disease: a study of cardiovascular effects.溴隐亭治疗帕金森病：心血管效应研究
J Neurol Neurosurg Psychiatry. 1981 May;44(5):426-9. doi: 10.1136/jnnp.44.5.426.
Zotero 插件